From: The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
Regulators | Expressions | Targets | Roles | Functions | Mechanisms | References |
---|---|---|---|---|---|---|
METTL3 | Up | miR-222-3p | Oncogene | Promotes tumor growth and metastasis | Promotes the expression of miR-222-3p and thus downregulates STK4 | [48] |
METTL3 | Up | TCF1 | Oncogene | Promotes proliferation and migration | Upregulates the IGF2BP2-mediated m6A modification of TCF1mRNA | [51] |
METTL3 | Down | c-Rel, RelA | Suppressor | Inhibits tumor growth | Inactivates the NF-κB pathway by cooperating with YTHDF2 and further reduces the accumulation of tumor-associated neutrophils | [52] |
METTL3 | Down | STEAP2 | Suppressor | Inhibits PTC proliferation, EMT, migration and metastasis | Enhances the stability of STEAP2 mRNA in an m6A-dependent manner and inhibits the Hedgehog signaling pathway | [53] |
FTO | Down | TP53 | Suppressor | Inhibits tumor progression | Targets m6A methylation of TP53 | [60] |
FTO | Down | APOE | Suppressor | Inhibits PTC glycolysis and growth | Suppresses the expression of APOE through IGF2BP2-mediated m6A modification | [62] |
FTO | Down | SLC7A11 | Suppressor | Promotes tumor ferroptosis | Downregulates the expression of SLC7A11 | [61] |
ALKBH5 | Down | TIAM1 | Suppressor | Inhibits proliferation and promotes ferroptosis | Suppresses the expression of TIAM1 by m6A modification | [69] |
IGF2BP2 | Up | lncRNA HAGLR | Oncogene | Promotes proliferation, migration and invasion | Promotes the expression of lncRNA HAGLR in an m6A-dependent manner | [75] |